New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
07:16 EDTVRTXVertex downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgraded Vertex Pharmaceuticals to Neutral with an $85 price target following yesterday's rally. The firm believes share are appropriately valued at current levels.
News For VRTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 22, 2014
06:39 EDTVRTXHepatitis C deal a blow to biotech bull market, The Street's Feuerstein says
Subscribe for More Information
December 15, 2014
09:06 EDTVRTXVertex names David Altshuler as Chief Scientific Officer
Subscribe for More Information
December 12, 2014
08:01 EDTVRTXPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
December 11, 2014
07:28 EDTVRTXCBI to hold a summit
2nd Specialty Data Optimization Summit is being held in Philadelphia on December 11.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use